SCHEMBL3754793

SCHEMBL3754793

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(OCC(O)CO)c4)c3)c2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.38
L3MBTL1 Q9Y468 4/20 0.35
PRMT5 O14744 4/20 0.35
WDR77 Q9BQA1 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 3/20 0.35
ADRB2 P07550 2/20 0.35
ADRB1 P08588 2/20 0.35
ADRB3 P13945 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.34
ABCB1 P08183 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
BUB1 O43683 1/20 0.33
WRN Q14191 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760088 0.87 KDM1A (0.40) PRMT5WDR77BUB1
SCHEMBL3762344 0.87 NPC1 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3760227 0.85 LRRK2 (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3760222 0.84 PIK3CA (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3759783 0.84 MEN1 (0.38) CARM1L3MBTL1SMN1; SMN2MAPK1GAA
SCHEMBL3756709 0.84 PIK3CA (0.47) L3MBTL1SMN1; SMN2GAAKMT2APIK3CD
SCHEMBL3762759 0.83 PRKDC (0.40) GAAGABRA1GABRG2GABRB3GABRA5
SCHEMBL3761577 0.83 PRKDC (0.42) L3MBTL1GABRA1GABRG2GABRB3GABRA5
SCHEMBL3766676 0.83 BUB1 (0.36) L3MBTL1MAPK1GAAKMT2AGABRA1
SCHEMBL3766682 0.83 KDM1A (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA CARM1 4440/4885L3MBTL1 1887/4885PRMT5 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.